Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer

By Reijm E.  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 387-394

Springer Publishing Company

Access to resources Recommend Favorite

miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2

By Yu Li   Lu Juan   Zhang Bao   Liu Xiong   Wang Lu   Li Si-Yang   Peng Xiao-Hong   Xu Xia   Tian Wen-Dong   Li Xiang-Ping  

Oncology Letters, Vol. 5, Iss. 4, 2013-04 ,pp. : 1223-1228

Spandidos Publications

Access to resources Recommend Favorite

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

By Lobbezoo Dorien   Kampen Roel   Voogd Adri   Dercksen M.   den Berkmortel Franchette   Smilde Tineke   Wouw Agnes   Peters Frank   Riel Johanna   Peters Natascha   Boer Maaike   Borm George   Tjan-Heijnen Vivianne  

Breast Cancer Research and Treatment, Vol. 141, Iss. 3, 2013-10 ,pp. : 507-514

Springer Publishing Company

Access to resources Recommend Favorite

miR342 is associated with estrogen receptorα expression and response to tamoxifen in breast cancer

By              

Experimental and Therapeutic Medicine, Vol. 5, Iss. 3, 2013-01 ,pp. : 813-818

Spandidos Publications

Access to resources Recommend Favorite

Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma

By Chen Hongyuan  

Clinical and Experimental Metastasis, Vol. 30, Iss. 5, 2013-06 ,pp. : 651-658

Springer Publishing Company

Access to resources Recommend Favorite